Clinical Trial Update: Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer. [Phase 2]

View source ↗

Summary

Phase II trial evaluated cetuximab with XELOX, followed by maintenance cetuximab plus capecitabine, as first-line treatment in elderly patients with metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cetuximab (cetuximab)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED